Management Approach for Polycystic Kidney Disease
The optimal management of polycystic kidney disease requires aggressive blood pressure control with ACE inhibitors or ARBs as first-line therapy, targeting BP <110/75 mmHg in adults and <50th percentile for age/sex/height in children, along with lifestyle modifications including sodium restriction and high water intake. 1
Blood Pressure Management
Target Blood Pressure
- Adults aged 18-49 with CKD G1-G2: Target BP of ≤110/75 mmHg (home monitoring) 1
- Adults aged ≥50 or with CKD G3-G5: Target systolic BP <120 mmHg 1
- Children and adolescents: Target BP <50th percentile for age, sex, and height, or <110/70 mmHg in adolescents 1
Antihypertensive Therapy
First-line agents: ACE inhibitors or ARBs 1
- Superior efficacy in patients with proteinuria
- Avoid dual RAAS blockade (no combination of ACEi + ARB)
Second-line agents: Based on individual assessment
Monitoring:
- Office BP measurements at every visit
- Consider ambulatory BP monitoring (ABPM) for children with height >120 cm 1
- Home BP monitoring to assess treatment efficacy
Proteinuria Management
- Screen regularly for albuminuria using laboratory ACR (more sensitive than dipstick) 1
- If proteinuria present, use ACE inhibitors or ARBs as primary treatment 1
- Target for proteinuria reduction should follow general CKD guidelines
Lifestyle Modifications
Sodium intake: Restrict dietary sodium 1, 2
- Follow recommended low salt intake for age
- Consider dietitian referral for practical implementation
Fluid intake: Encourage high water intake 1, 2, 3
- Helps slow disease progression
- Based on thirst and individual needs
Physical activity: Promote regular exercise 1, 2
- Moderate-intensity physical activity (150 minutes/week for adults)
- Strength training at least twice weekly
- Caution with contact sports in those with enlarged kidneys
Diet:
Monitoring Disease Progression
Blood pressure monitoring:
- Annual standardized office BP measurement
- Consider 24-hour ABPM in high-risk patients
Kidney function assessment:
- Regular monitoring of eGFR
- Albuminuria/proteinuria assessment
Imaging:
Pharmacologic Therapies
Vasopressin antagonists (tolvaptan):
Avoid:
Management of Complications
Kidney pain:
Hematuria:
- Educate patients about possibility of gross hematuria 1
- Conservative management in most cases
Nephrolithiasis:
- Same management as general population
- Obstructing stones require specialized care 1
Special Considerations
Pregnancy
- Stop ACE inhibitors, ARBs, tolvaptan before conception 1
- Preconception counseling regarding genetic transmission 1
Children with ADPKD
- Annual BP monitoring
- Early intervention for hypertension
- Multidisciplinary care approach 1
Pitfalls to Avoid
- Underestimating hypertension: Masked hypertension is common; consider ABPM 1
- Inadequate BP control: Aggressive BP management is critical for slowing disease progression
- Overuse of imaging: Frequent imaging in asymptomatic children has limited value 1
- Inappropriate medications: Avoid dual RAAS blockade and use diuretics cautiously 1
- Ignoring lifestyle factors: Diet, exercise, and fluid intake are fundamental to management 2, 3
By implementing this comprehensive management approach, progression of polycystic kidney disease can be slowed, complications minimized, and quality of life improved.